COMPOUNDS WHICH SELECTIVELY MODULATE THE CB2 RECEPTOR

Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Saved in:
Bibliographic Details
Main Authors BARTOLOZZI, ALESSANDRA, RIETHER, DORIS, SCOTT, ROBERT, JOHN, MUSHI, INNOCENT, AMOUZEGH, PATRICIA, BLUMIRE, NIGEL JAMES, ERMANN, MONIKA, ZINDELL, RENEE
Format Patent
LanguageEnglish
French
German
Published 01.08.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Bibliography:Application Number: EP20100765707